Similar articles

• Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study.

  Antman EM, Wenger TL, Butler VP Jr, Haber E, Smith TW. Antman EM, et al. Circulation. 1990 Jun;81(6):1744-52. doi: 10.1161/01.cir.81.6.1744. Circulation. 1990. PMID: 2188752 Clinical Trial.
• Treatment of digitalis intoxication with emphasis on the clinical use of digoxin immune Fab.

  Allen NM, Dunham GD. Allen NM, et al. DICP. 1990 Oct;24(10):991-8. doi: 10.1177/106002809002401015. DICP. 1990. PMID: 2244414 Review.
• Results of multicenter studies of digoxin-specific antibody fragments in managing digitalis intoxication in the pediatric population.

  Woolf AD, Wenger TL, Smith TW, Lovejoy FH Jr. Woolf AD, et al. Am J Emerg Med. 1991 Mar;9(2 Suppl 1):16-20; discussion 33-4. doi: 10.1016/0735-6757(91)90162-d. Am J Emerg Med. 1991. PMID: 1997016 Review.
• [Fab fragments of antidigoxin antibodies and acute digitalis poisoning].

  Tribouilloy C, Vovan A, Isorni C, Castier B, Lesbre JP. Tribouilloy C, et al. Ann Cardiol Angeiol (Paris). 1986 Oct 30;35(8):469-73. Ann Cardiol Angeiol (Paris). 1986. PMID: 3813453 French.
• Digoxin Immune Fab therapy in the management of digitalis intoxication: safety and efficacy results of an observational surveillance study.

  Hickey AR, Wenger TL, Carpenter VP, Tilson HH, Hlatky MA, Furberg CD, Kirkpatrick CH, Strauss HC, Smith TW. Hickey AR, et al. J Am Coll Cardiol. 1991 Mar 1;17(3):590-8. doi: 10.1016/s0735-1097(10)80170-6. J Am Coll Cardiol. 1991. PMID: 1993775